22
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Sirt1 contributes critically to the redox-dependent fate of neural progenitors.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Repair processes that are activated in response to neuronal injury, be it inflammatory, ischaemic, metabolic, traumatic or other cause, are characterized by a failure to replenish neurons and by astrogliosis. The underlying molecular pathways, however, are poorly understood. Here, we show that subtle alterations of the redox state, found in different brain pathologies, regulate the fate of mouse neural progenitor cells (NPCs) through the histone deacetylase (HDAC) Sirt1. Mild oxidation or direct activation of Sirt1 suppressed proliferation of NPCs and directed their differentiation towards the astroglial lineage at the expense of the neuronal lineage, whereas reducing conditions had the opposite effect. Under oxidative conditions in vitro and in vivo, Sirt1 was upregulated in NPCs, bound to the transcription factor Hes1 and subsequently inhibited pro-neuronal Mash1. In utero shRNA-mediated knockdown of Sirt1 in NPCs prevented oxidation-mediated suppression of neurogenesis and caused upregulation of Mash1 in vivo. Our results provide evidence for an as yet unknown metabolic master switch that determines the fate of neural progenitors.

          Related collections

          Author and article information

          Journal
          Nat. Cell Biol.
          Nature cell biology
          Springer Nature
          1476-4679
          1465-7392
          Apr 2008
          : 10
          : 4
          Affiliations
          [1 ] Cecilie Vogt Clinic for Neurology in the Helios Klinikum Berlin-Buch, Charité - Universitätsmedizin Berlin, and Max Delbrück Center for Molecular Medicine, Charitéplatz 1, 10117 Berlin, Germany.
          Article
          ncb1700
          10.1038/ncb1700
          18344989
          99323c97-566e-4756-ba46-f20ac63afee7
          History

          Comments

          Comment on this article